These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38952291)

  • 1. Chlorogenic acid alleviates renal fibrosis by reducing lipid accumulation in diabetic kidney disease through suppressing the Notch1 and Stat3 signaling pathway.
    Yang XY; Jiang D; Wang YZ; Duan MY; Huang YW; Wang XJ; Xiang ZM; Sheng J; Zhu QQ
    Ren Fail; 2024 Dec; 46(2):2371988. PubMed ID: 38952291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease.
    Liu J; Ren J; Zhou L; Tan K; Du D; Xu L; Cao W; Zhang Y
    J Ethnopharmacol; 2024 Nov; 334():118517. PubMed ID: 38972525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MSU crystallization promotes fibroblast proliferation and renal fibrosis in diabetic nephropathy via the ROS/SHP2/TGFβ pathway.
    Li J; Zhang J; Zhao X; Tian L
    Sci Rep; 2024 Aug; 14(1):20251. PubMed ID: 39215017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptolide prevents extracellular matrix accumulation in experimental diabetic kidney disease by targeting microRNA-137/Notch1 pathway.
    Han F; Wang S; Chang Y; Li C; Yang J; Han Z; Chang B; Sun B; Chen L
    J Cell Physiol; 2018 Mar; 233(3):2225-2237. PubMed ID: 28695984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis.
    Jia J; Tan R; Xu L; Wang H; Li J; Su H; Zhong X; Liu P; Wang L
    Int Immunopharmacol; 2024 Jun; 135():112303. PubMed ID: 38776855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sinomenine improve diabetic nephropathy by inhibiting fibrosis and regulating the JAK2/STAT3/SOCS1 pathway in streptozotocin-induced diabetic rats.
    Zhu M; Wang H; Chen J; Zhu H
    Life Sci; 2021 Jan; 265():118855. PubMed ID: 33278392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gliquidone Alleviates Diabetic Nephropathy by Inhibiting Notch/Snail Signaling Pathway.
    Tian H; Yang J; Xie Z; Liu J
    Cell Physiol Biochem; 2018; 51(5):2085-2097. PubMed ID: 30522115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C5 activation promotes type 2 diabetic kidney disease via activating STAT3 pathway and disrupting the gut-kidney axis.
    Li L; Wei T; Liu S; Wang C; Zhao M; Feng Y; Ma L; Lu Y; Fu P; Liu J
    J Cell Mol Med; 2021 Jan; 25(2):960-974. PubMed ID: 33280239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro.
    Gwon MG; An HJ; Gu H; Kim YA; Han SM; Park KK
    J Mol Med (Berl); 2021 Sep; 99(9):1265-1277. PubMed ID: 34031696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
    Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
    Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silymarin nanoliposomes attenuate renal injury on diabetic nephropathy rats via co-suppressing TGF-β/Smad and JAK2/STAT3/SOCS1 pathway.
    Chen Y; Chen L; Yang T
    Life Sci; 2021 Apr; 271():119197. PubMed ID: 33577847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease.
    Falkevall A; Mehlem A; Palombo I; Heller Sahlgren B; Ebarasi L; He L; Ytterberg AJ; Olauson H; Axelsson J; Sundelin B; Patrakka J; Scotney P; Nash A; Eriksson U
    Cell Metab; 2017 Mar; 25(3):713-726. PubMed ID: 28190774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senolytic combination of dasatinib and quercetin attenuates renal damage in diabetic kidney disease.
    Guo X; Wen S; Wang J; Zeng X; Yu H; Chen Y; Zhu X; Xu L
    Phytomedicine; 2024 Jul; 130():155705. PubMed ID: 38761776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small extracellular vesicles-shuttled miR-23a-3p from mesenchymal stem cells alleviate renal fibrosis and inflammation by inhibiting KLF3/STAT3 axis in diabetic kidney disease.
    Li Q; Liu J; Su R; Zhen J; Liu X; Liu G
    Int Immunopharmacol; 2024 Sep; 139():112667. PubMed ID: 39018690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway.
    Zhang Q; He L; Dong Y; Fei Y; Wen J; Li X; Guan J; Liu F; Zhou T; Li Z; Fan Y; Wang N
    FASEB J; 2020 Jun; 34(6):7500-7519. PubMed ID: 32281218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupleurum polysaccharides ameliorated renal injury in diabetic mice associated with suppression of HMGB1-TLR4 signaling.
    Liu ZZ; Weng HB; Zhang LJ; Pan LY; Sun W; Chen HX; Chen MY; Zeng T; Zhang YY; Chen DF; Li H
    Chin J Nat Med; 2019 Sep; 17(9):641-649. PubMed ID: 31526499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morroniside attenuates podocytes lipid deposition in diabetic nephropathy: A network pharmacology, molecular docking and experimental validation study.
    Chen Y; Chen M; Zhu W; Zhang Y; Liu P; Li P
    Int Immunopharmacol; 2024 Sep; 138():112560. PubMed ID: 38959541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling.
    Zhong D; Chen J; Qiao R; Song C; Hao C; Zou Y; Bai M; Su W; Yang B; Sun D; Jia Z; Sun Y
    Cell Rep; 2024 Apr; 43(4):114075. PubMed ID: 38583151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
    Koszegi S; Molnar A; Lenart L; Hodrea J; Balogh DB; Lakat T; Szkibinszkij E; Hosszu A; Sparding N; Genovese F; Wagner L; Vannay A; Szabo AJ; Fekete A
    J Physiol; 2019 Jan; 597(1):193-209. PubMed ID: 30324679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of berberine on matrix accumulation and NF-kappa B signal pathway in alloxan-induced diabetic mice with renal injury.
    Liu W; Zhang X; Liu P; Shen X; Lan T; Li W; Jiang Q; Xie X; Huang H
    Eur J Pharmacol; 2010 Jul; 638(1-3):150-5. PubMed ID: 20447389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.